The longitudinal relationship between patient-reported outcomes and clinical characteristics among patients with focal segmental glomerulosclerosis in the Nephrotic Syndrome Study Network

Author:

Troost Jonathan P1,Waldo Anne1,Carlozzi Noelle E2,Murphy Shannon3,Modersitzki Frank4,Trachtman Howard5,Nachman Patrick H6,Reidy Kimberly J7,Selewski David T8,Herreshoff Emily G1,Srivastava Tarak9,Gibson Keisha L3,Derebail Vimal K3,Lin Jen Jar10,Hingorani Sangeeta11,Fornoni Alessia12,Fervenza Fernando C13,Sambandam Kamalanathan14,Athavale Ambarish M15,Kopp Jeffrey B16,Reich Heather N17,Adler Sharon G18,Greenbaum Larry A19,Dell Katherine M20,Appel Gerald21,Wang Chia-shi19ORCID,Sedor John22,Kaskel Frederick J7,Lafayette Richard A23,Atkinson Meredith A24,Lieske John C13,Sethna Christine B25,Kretzler Matthias26,Hladunewich Michelle A17,Lemley Kevin V27,Brown Elizabeth28,Meyers Kevin E29,Gadegbeku Crystal A30,Holzman Lawrence B31,Jefferson Jonathan Ashley32,Tuttle Katherine R3334,Singer Pamela25,Hogan Marie C13,Cattran Daniel C35,Barisoni Laura3637,Gipson Debbie S1,Sedor J,Dell K,Schachere M,Lemley K,Whitted L,Srivastava T,Haney C,Sethna C,Gurusinghe S,Appel G,Toledo M,Greenbaum L,Wang C,Lee B,Adler S,Nast C,La Page J,Stroger John H,Athavale A,Itteera M,Neu A,Boynton S,Fervenza F,Hogan M,Lieske J,Chernitskiy V,Kaskel F,Reidy K,Kopp J,Castro-Rubio E,Brede E,Blake J,Trachtman H,Zhdanova O,Modersitzki F,Vento S,Lafayette R,Mehta K,Gadegbeku C,Johnstone D,Pfeffer Z,Cattran D,Hladunewich M,Reich H,Ling P,Romano M,Fornoni A,Barisoni L,Bidot C,Kretzler M,Gipson D,Williams A,Pitter R,Derebail V,Gibson K,Grubbs S,Froment A,Holzman L,Meyers K,Kallem K,Cerecino F J,Sambandam K,Brown E,Johnson N,Jefferson A,Hingorani S,Tuttle K,Klepach K,Kelton M,Cooper A,Freedman B,Lin J J,Spainhour M,Gray S,Kretzler M,Barisoni L,Gadegbeku C,Gillespie B,Gipson D,Holzman L,Mariani L,Sampson M,Song P,Troost J,Zee J,Herreshoff E,Kincaid C,Lienczewski C,Mainieri T,Williams A,Avila-Casado C,Bagnasco S,Gaut J,Hewitt S,Hodgin J,Lemley K,Mariani L,Palmer M,Rosenberg A,Royal V,Thomas D,Zee J,Barisoni L,Nast C,Abbott K,Roy C,Urv T,Brooks P J,Sedor J,Dell K,Schachere M,Lemley K,Whitted L,Srivastava T,Haney C,Sethna C,Gurusinghe S,Appel G,Toledo M,Greenbaum L,Wang C,Lee B,Adler S,Nast C,La Page J,Stroger John H,Athavale A,Itteera M,Neu A,Boynton S,Fervenza F,Hogan M,Lieske J,Chernitskiy V,Kaskel F,Reidy K,Kopp J,Castro-Rubio E,Brede E,Blake J,Trachtman H,Zhdanova O,Modersitzki F,Vento S,Lafayette R,Mehta K,Gadegbeku C,Johnstone D,Pfeffer Z,Cattran D,Hladunewich M,Reich H,Ling P,Romano M,Fornoni A,Barisoni L,Bidot C,Kretzler M,Gipson D,Williams A,Pitter R,Derebail V,Gibson K,Grubbs S,Froment A,Holzman L,Meyers K,Kallem K,Cerecino F J,Sambandam K,Brown E,Johnson N,Jefferson A,Hingorani S,Tuttle K,Klepach K,Kelton M,Cooper A,Freedman B,Lin J J,Spainhour M,Gray S,Kretzler M,Barisoni L,Gadegbeku C,Gillespie B,Gipson D,Holzman L,Mariani L,Sampson M,Song P,Troost J,Zee J,Herreshoff E,Kincaid C,Lienczewski C,Mainieri T,Williams A,Avila-Casado C,Bagnasco S,Gaut J,Hewitt S,Hodgin J,Lemley K,Mariani L,Palmer M,Rosenberg A,Royal V,Thomas D,Zee J,Barisoni L,Nast C,Abbott K,Roy C,Urv T,Brooks P J,

Affiliation:

1. Department of Pediatrics, Division of Nephrology, University of Michigan, Ann Arbor, MI, USA

2. Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI, USA

3. University of North Carolina Kidney Center at Chapel Hill, Chapel Hill, NC, USA

4. Department of Medicine, Division of Nephrology, New York University Langone Health, New York, NY, USA

5. Department of Pediatrics, Division of Nephrology, New York University Langone Health, New York, NY, USA

6. Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, MN, USA

7. Department of Pediatrics, Division of Nephrology, Albert Einstein College of Medicine, Montefiore Medical Center, New York, NY, USA

8. Department of Pediatrics, Division of Nephrology, Medical University of South Carolina, Charleston, SC, USA

9. Section of Nephrology, Children's Mercy Hospital and University of Missouri at Kansas City, Kansas City, MO, USA

10. Division of Pediatric Nephrology, Brenner Children's Hospital, Wake Forest University, Winston-Salem, NC, USA

11. Department of Pediatrics, Division of Nephrology, Seattle Children's Hospital and University of Washington, Seattle, WA, USA

12. Department of Medicine, Katz Family Division of Nephrology and Hypertension, University of Miami Miller School of Medicine, Miami, FL, USA

13. Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA

14. Department of Internal Medicine, Division of Nephrology, UT Southwestern Medical Center, Dallas, TX, USA

15. Division of Nephrology, Core Faculty, Internal Medicine Residency Program, John H. Stroger Jr. Hospital of Cook County, Chicago, IL, USA

16. Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA

17. Department of Medicine, Division of Nephrology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada

18. Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor-University of California Los Angeles Medical Center, Torrance, CA, USA

19. Department of Pediatrics, Division of Pediatric Nephrology, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, USA

20. Center for Pediatric Nephrology, Cleveland Clinic Children's and Case Western Reserve University, Cleveland, OH, USA

21. Division of Nephrology, Columbia University Medical Center, New York, NY, USA

22. Department of Nephrology, Cleveland Clinic, Cleveland, OH, USA

23. Department of Medicine, Division of Nephrology, Stanford University, Stanford, CA, USA

24. Division of Pediatric Nephrology, Johns Hopkins University School of Medicine, Baltimore, MD, USA

25. Pediatric Nephrology, Cohen Children's Medical Center of New York, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA

26. Department of Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, MI, USA

27. Division of Nephrology, Children's Hospital Los Angeles, Los Angeles, CA, USA

28. Department of Pediatrics, Division of Nephrology, University of Texas Southwestern Medical Center, Dallas, TX, USA

29. Department of Pediatrics, Division of Nephrology, Children's Hospital of Philadelphia, Philadelphia, PA, USA

30. Division of Nephrology, Temple University School of Medicine, Philadelphia, PA, USA

31. Renal-Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

32. Department of Medicine, Division of Nephrology, University of Washington, Seattle, WA, USA

33. Providence Health Care, Providence Medical Research Center, Spokane, WA, USA

34. Nephrology Division, Kidney Research Institute and Institute for Translational Health Sciences, University of Washington, Seattle, WA, USA

35. Department of Medicine, Division of Nephrology, University Health Network, University of Toronto, Toronto, ON, Canada

36. Department of Pathology, Division of Nephrology, Duke University, Durham, NC, USA

37. Department of Medicine, Division of Nephrology, Duke University, Durham, NC, USA

Abstract

Abstract Background Understanding the relationship between clinical and patient-reported outcomes (PROs) will help support clinical care and future clinical trial design of novel therapies for focal segmental glomerulosclerosis (FSGS). Methods FSGS patients ≥8 years of age enrolled in the Nephrotic Syndrome Study Network completed Patient-Reported Outcomes Measurement Information System PRO measures of health-related quality of life (HRQoL) (children: global health, mobility, fatigue, pain interference, depression, anxiety, stress and peer relationships; adults: physical functioning, fatigue, pain interference, sleep impairment, mental health, depression, anxiety and social satisfaction) at baseline and during longitudinal follow-up for a maximum of 5 years. Linear mixed-effects models were used to determine which demographic, clinical and laboratory features were associated with PROs for each of the eight children and eight adults studied. Results There were 45 children and 114 adult FSGS patients enrolled that had at least one PRO assessment and 519 patient visits. Multivariable analyses among children found that edema was associated with global health (−7.6 points, P = 0.02) and mobility (−4.2, P = 0.02), the number of reported symptoms was associated with worse depression (−2.7 per symptom, P = 0.009) and anxiety (−2.3, P = 0.02) and the number of emergency room (ER) visits in the prior 6 months was associated with worse mobility (−2.8 per visit, P < 0.001) and fatigue (−2.4, P = 0.03). Multivariable analyses among adults found the number of reported symptoms was associated with worse function in all eight PROMIS measures and the number of ER visits was associated with worse fatigue, pain interference, sleep impairment, depression, anxiety and social satisfaction. Laboratory markers of disease severity (i.e. proteinuria, estimated glomerular filtration rate and serum albumin) did not predict PRO in multivariable analyses, with the single exception of complete remission and better pain interference scores among children (+9.3, P = 0.03). Conclusions PROs provide important information about HRQoL for persons with FSGS that is not captured solely by the examination of laboratory-based markers of disease. However, it is critical that instruments capture the patient experience and FSGS clinical trials may benefit from a disease-specific instrument more sensitive to within-patient changes.

Funder

Nephrotic Syndrome Study Network Consortium

National Institutes of Health Rare Disease Clinical Research Network

Office of Rare Diseases Research

National Center for Advancing Translational Sciences

NIDDK

University of Michigan

NephCure Kidney International

Halpin Foundation

Charles Woodson Pilot Research Award

University of Michigan Department of Pediatrics

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Reference25 articles.

1. KDIGO clinical practice guideline for glomerulonephritis;Kidney Int Suppl,2012

2. Recent advances in treatments of primary focal segmental glomerulosclerosis in children;Han;Biomed Res Int,2016

3. The treatment of idiopathic focal segmental glomerulosclerosis in adults;Hogan;Adv Chronic Kidney Dis,2014

4. Focal segmental glomerulosclerosis;D’Agati;N Engl J Med,2011

Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3